Vor Biopharma Ownership | Who Owns Vor Biopharma?
Vor Biopharma Ownership Summary
Vor Biopharma is owned by 56.33% institutional investors, 12.09% insiders, and 31.58% retail investors. Blackrock is the largest institutional shareholder, holding 0.73% of VOR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.10% of its assets in Vor Biopharma shares.
VOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vor Biopharma | 56.33% | 12.09% | 31.58% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 497.70K | 0.73% | $497.70K |
| Millennium management | 261.84K | 0.38% | $290.64K |
| Susquehanna group, llp | 115.03K | 0.17% | $127.68K |
| Acadian asset management | 86.69K | 0.13% | $95.00K |
| Bank of america corp /de/ | 25.16K | 0.04% | $25.16K |
| Sei investments | 17.60K | 0.03% | $17.60K |
| Aqr capital management | 11.20K | 0.02% | $11.20K |
| Rhumbline advisers | 5.50K | 0.01% | $5.50K |
| Macquarie group | 1.95K | 0.00% | $1.95K |
| Russell investments group | 1.23K | 0.00% | $1.23K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Acadian asset management | 86.69K | 0.00% | $95.00K |
| Millennium management | 261.84K | 0.00% | $290.64K |
| Geode capital management | - | - | - |
| Proshare advisors | - | - | - |
| Nbc securities | - | - | - |
| Legal & general group | - | - | - |
| Marshall wace, llp | - | - | - |
| Renaissance | - | - | - |
| Gsa capital partners llp | - | - | - |
| Voya investment management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Susquehanna group, llp | 115.03K | - | 115.03K |
| Sei investments | 17.60K | - | 17.60K |
| Aqr capital management | 11.20K | - | 11.20K |
| Acadian asset management | 86.69K | 0.00% | 5.38K |
| Macquarie group | 1.95K | - | 1.95K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -39.65M |
| Paradigm biocapital advisors lp | - | - | -6.46M |
| 5am venture management | - | - | -6.36M |
| Hudson bay capital management lp | - | - | -2.47M |
| Fmr | - | - | -2.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sei investments | 17.60K | - | 17.60K | $17.60K |
| Aqr capital management | 11.20K | - | 11.20K | $11.20K |
| Macquarie group | 1.95K | - | 1.95K | $1.95K |
| Russell investments group | 1.23K | - | 1.23K | $1.23K |
| Allworth financial lp | 60.00 | - | 60.00 | $98.00 |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Point72 (difc) | -26.00 |
| Nisa investment advisors | -45.00 |
| Citadel advisors | -100.00 |
| Smartleaf asset management | -102.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 45 | 9.76% | 3,764,067 | -93.40% | 56 | 2.72% | 17 | -10.53% | 22 | 100.00% |
| Jun 30, 2025 | 41 | -2.38% | 57,027,241 | 7.15% | 45 | 2.50% | 21 | 16.67% | 11 | -35.29% |
| Mar 31, 2025 | 44 | -16.98% | 60,090,600 | -1.40% | 48 | 0.61% | 18 | -10.00% | 18 | 12.50% |
| Dec 31, 2024 | 52 | -5.45% | 60,931,305 | 27.38% | 88 | 1.82% | 20 | 11.11% | 16 | -11.11% |
| Sep 30, 2024 | 55 | -19.12% | 47,833,717 | -12.27% | 69 | 1.09% | 19 | -51.28% | 18 | 5.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 2.12M | 3.10% | - |
| Fidelity Growth Compy Commingled Pl S | 1.96M | 1.57% | -207.80K |
| Vanguard US Total Market Shares ETF | 1.39M | 1.11% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.36M | 1.07% | -29.89K |
| Fidelity Growth Company Fund | 1.27M | 1.02% | -140.15K |
| Fidelity Select Biotechnology | 614.60K | 0.90% | - |
| Fidelity Capital Appreciation | 610.40K | 0.49% | - |
| Fidelity VIP Growth Initial | 618.39K | 0.49% | - |
| Fidelity Advisor Equity Growth I | 474.17K | 0.37% | - |
| Fidelity Growth Company K6 | 438.61K | 0.35% | -43.30K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Sell | $617.42K | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. | Sell | $2.38M | |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. | Sell | $1.03M | |
| Oct 29, 2025 | RA CAPITAL MANAGEMENT, L.P. | Sell | $6.34M | |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. | Sell | $1.49M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 56 |
| 2025 Q3 | - | 14 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 2 |
| 2024 Q4 | 2 | 1 |
VOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools